![]() ![]() Flumazenil is used as a general anesthesia for complete or partial reversal of the sedative effects caused by benzodiazepines in patients, which it is expected drive growth of the global flumazenil market. ![]() For the treatment of anxiety disorders antidepressant drugs such as benzodiazepines are prescribed for the patient. For instance, according to data published in April 2018, by Our World in Data, a scientific online publication, about 284 million people were suffering from anxiety disorders globally in the year 2017. Increasing number of people with anxiety disorders is expected to propel growth of the global flumazenil market over the forecast period. Increasing number of anxiety disorders among people is expected to drive growth of the global flumazenil market over the forecast period. Flumazenil, is an imidazobenzodiazepine derivative, which disaffects the actions of benzodiazepines on the central nervous system. Flumazenil Injection contain active ingredients such as flumazenil and inactive ingredients such as acetic acid, hydrochloric acid, sodium hydroxide, methylparaben, sodium chloride, propylparaben, and edetate disodium. For instance, in January 2018, Hikma Pharmaceuticals, a developer of medicines, had launched its product Flumazenil Injection, USP 0.5 mg/5 mL. Market players are launching new products, which is expected to drive growth of the global flumazenil market over the forecast period. This is expected to drive growth of the global flumazenil market over the forecast period. Market players are concentrating on launching of new products. Global flumazenil market is estimated to be valued at US$ 20.528 Mn in 2022 and is expected to exhibit a CAGR of 2.8% over the forecast period (2022-2030)įigure 1: Global Flumazenil Market Share, (%), Analysis, By Application, 2022 FDA has published the data of discontinuation of flumazenil injection, which was present in the form of 0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial. Food and Drug Administration introduced guidelines to the industries to notify FDA about the permanent discontinuance or interruption in manufacturing of drugs Under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Supply chain affected the transport and production of Flumazenil, which has hampered the supply of Flumazenil in market.ĭiscontinuation of Flumazenil drug from market is expected to restrict the global flumazenil market. Several countries across the world have reported an overall shortage of several types of drugs at the retail level. For instance, according to data reported by United Nations Office on Drugs and Crime in July 2020, the effective measures taken to control the spread of COVID-19 pandemic has at the end badly affected to drug supply chain. ![]() The COVID-19 pandemic is expected to hamper growth of the global flumazenil market, owing to disturbance in drug supply chain. Global Flumazenil Market - Impact of the Coronavirus (COVID-19) Pandemic Flumazenil is administered in the vein in diluted or undiluted form. Flumazenil is also used in anesthesia to wake up the patient after diagnostic tests. Medicinally, it performances as antagonist and antidote to benzodiazepines. Information and Communication Technologyįlumazenil is an antagonist directed through injection or intranasally. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |